ArticleClinical case reports2017

Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine.

Signe Risum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.